FONCTION RESPIRATOIRE ET CEC

02/2008

(1) Anton-Pacheco JL, Galletti L, Cabezali D, Luna C, Gonzalez dO, Sanchez-Solis dQ: Management of bilateral congenital bronchial stenosis in an infant. J.Pediatr.Surg. 2007; 42: E1-E3
(2) Cislaghi F, Condemi AM, Corona A: Predictors of prolonged mechanical ventilation in a cohort of 3,269 CABG patients. Minerva Anestesiol. 2007; 73: 615-21
(3) Ferrer J, Rodriguez E, Roman A, Bravo C, Roldan J, Hermosilla E, Canela M: Factors related to postoperative mortality in lung transplantation for emphysema. Transplant.Proc. 2007; 39: 3317-22
(4) Gasparovic H, Plestina S, Sutlic Z, Husedzinovic I, Coric V, Ivancan V, Jelic I: Pulmonary lactate release following cardiopulmonary bypass. Eur.J.Cardiothorac.Surg. 2007; 32: 882-7
(5) Heijmans JH, Liem KS, Damoiseaux GM, Maessen JG, Roekaerts PM: Pulmonary function and inflammatory markers in patients undergoing coronary revascularisation with or without cardiopulmonary bypass. Anaesthesia. 2007; 62: 1233-40
(6) Klass O, Fischer UM, Antonyan A, Bosse M, Fischer JH, Bloch W, Mehlhorn U: Pneumocyte apoptosis induction during cardiopulmonary bypass: effective prevention by radical scavenging using N-acetylcysteine. J.Invest Surg. 2007; 20: 349-56
(7) Rex S, Schaelte G, Metzelder S, Flier S, de Waal EE, Autschbach R, Rossaint R, Buhre W: Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial. Acta Anaesthesiol.Scand. 2008; 52: 65-72
(8) Shao H, Shen Y, Liu H, Dong G, Qiang J, Jing H: Simvastatin suppresses lung inflammatory response in a rat cardiopulmonary bypass model. Ann.Thorac.Surg. 2007; 84: 2011-8
(9) Simon C, Cavarretta E, Capuano F, Bianchini R, Roscitano A, Tonelli E, Sinatra R: Severe hypoxaemia after weaning from cardiopulmonary bypass: a case report. J.Cardiovasc.Med.(Hagerstown.). 2007; 8: 956-8
(10) Taniguchi S, Fukuda I, Minakawa M, Watanabe K, Daitoku K, Suzuki Y: Emergency pulmonary embolectomy during the second trimester of pregnancy: report of a case. Surg.Today. 2008; 38: 59-61
(11) Theologou T, Tewari P, Pointon K, Mitchell IM: Pulmonary thromboembolism with floating thrombus trapped in patent foramen ovale. Ann.Thorac.Surg. 2007; 84: 2104-6

08-10/2007

(1) Toraman F, Evrenkaya S, Senay S, Karabulut H, Alhan C: Adjusting oxygen fraction to avoid hyperoxemia during cardiopulmonary bypass. Asian Cardiovasc.Thorac.Ann. 2007; 15: 303-6
(2) Simon C, Cavarretta E, Capuano F, Bianchini R, Roscitano A, Tonelli E, Sinatra R: Severe hypoxaemia after weaning from cardiopulmonary bypass: a case report. J.Cardiovasc.Med.(Hagerstown.). 2007; 8: 956-8
(3) Santos AR, Heidemann SM, Walters HL, III, Delius RE: Effect of inhaled corticosteroid on pulmonary injury and inflammatory mediator production after cardiopulmonary bypass in children*. Pediatr.Crit Care Med. 2007; 8: 465-9
(4) Reddy SL, Grayson AD, Griffiths EM, Pullan DM, Rashid A: Logistic risk model for prolonged ventilation after adult cardiac surgery. Ann.Thorac.Surg. 2007; 84: 528-36
(5) Rasmussen BS, Laugesen H, Sollid J, Gronlund J, Rees SE, Toft E, Gjedsted J, Dethlefsen C, Tonnesen E: Oxygenation and release of inflammatory mediators after off-pump compared with after on-pump coronary artery bypass surgery. Acta Anaesthesiol.Scand. 2007; 51: 1202-10
(6) Prekker ME, Herrington CS, Hertz MI, Radosevich DM, Dahlberg PS: Early Trends in PaO(2)/fraction of inspired oxygen ratio predict outcome in lung transplant recipients with severe primary graft dysfunction. Chest. 2007; 132: 991-7
(7) Mittnacht AJ, Joashi U, Nguyen K, Chin C, Srivastava S, Hollinger I: Continuous positive airway pressure and lung separation during cardiopulmonary bypass to facilitate congenital heart surgery via the right thorax in children. Paediatr.Anaesth. 2007; 17: 693-6
(8) Kermeen FD, McNeil KD, Fraser JF, McCarthy J, Ziegenfuss MD, Mullany D, Dunning J, Hopkins PM: Resolution of severe ischemia-reperfusion injury post-lung transplantation after administration of endobronchial surfactant. J.Heart Lung Transplant. 2007; 26: 850-6
(9) John LC, Ervine IM: A study assessing the potential benefit of continued ventilation during cardiopulmonary bypass. Interact.Cardiovasc.Thorac.Surg. 2007; .:
(10) Huang H, Kong X, Zhu D, Wang W, Zhang H: Autologous lung used as a substitute of oxygenator in cardiopulmonary bypass can preserve postoperative respiratory function. ASAIO J. 2007; 53: 456-9

01/2007

(1) Saitoh M, Tsuchida M, Koike T, Satoh K, Haga M, Aoki T, Toyabe S, Hayashi J: Ultrafiltration attenuates cardiopulmonary bypass-induced acute lung injury in a canine model of single-lung transplantation. J.Thorac.Cardiovasc.Surg. 2006; 132: 1447-54

(2) Van der Vorst MM, Wildschut E, Houmes RJ, Gischler SJ, Kist-Van Holthe JE, Van der Heijden AJ, Burggraaf J, Tibboel D: Evaluation of furosemide regimens in neonates treated with extracorporeal membrane oxygenation. Crit Care. 2006; 10: R168

(3) Maruo A, Okita Y, Okada K, Yamashita T, Tobe S, Tanimura N: Surgical experience for the pulmonary artery sarcoma. Ann.Thorac.Surg. 2006; 82: 2014-6

(4) Murphy TW, Reay CA, Sims AJ, Smith JH: Serial measurement of leak conductance around uncuffed endotracheal tubes in children after cardiopulmonary bypass. Paediatr.Anaesth. 2006; 16: 1300-1

(5) Schreiber C, Horer J, Vogt M, Fratz S, Kunze M, Galm C, Eicken A, Lange R: A new treatment option for pulmonary valvar insufficiency: first experiences with implantation of a self-expanding stented valve without use of cardiopulmonary bypass. Eur.J.Cardiothorac.Surg. 2007; 31: 26-30

(6) Brown DM, Holt DW, Edwards JT, Burnett RJ, III: Normoxia vs. hyperoxia: impact of oxygen tension strategies on outcomes for patients receiving cardiopulmonary bypass for routine cardiac surgical repair. J.Extra.Corpor.Technol. 2006; 38: 241-8

(7) Hubert B, Troncy E, Gauvin D, Taha R, Pang D, Beauchamp G, Radomski A, Radomski MW, Blaise GA: Increased alveolar and plasma gelatinases activity during postpump syndrome: inhibition by inhaled nitric oxide. J.Cardiovasc.Pharmacol. 2006; 48: 71-8

(8) Stollings JL, Oyen LJ: Oxygen therapeutics: oxygen delivery without blood. Pharmacotherapy. 2006; 26: 1453-64

(9) Johnson G, Tamblyn J: Model of pCO2 gap during hypothermic cardiopulmonary bypass. ASAIO J. 2006; 52: 588-91

(10) Altmay E, Karaca P, Yurtseven N, Ozkul V, Aksoy T, Ozler A, Canik S: Continuous positive airway pressure does not improve lung function after cardiac surgery. Can.J.Anaesth. 2006; 53: 919-25

(11) Miranda DR, Klompe L, Mekel J, Struijs A, van Bommel J, Lachmann B, Bogers AJ, Gommers D: Open lung ventilation does not increase right ventricular outflow impedance: An echo-Doppler study. Crit Care Med. 2006; 34: 2555-60

(12) Zielinski M, Kuzdzal J: Pulmonary resections for T4 non-small cell lung cancer with support of cardiopulmonary bypass. Eur.J.Cardiothorac.Surg. 2006; 30: 686-7

(13) Mathur NN, Peek GJ, Bailey CM, Elliott MJ: Strategies for managing Type IV laryngotracheoesophageal clefts at Great Ormond Street Hospital for Children. Int.J.Pediatr.Otorhinolaryngol. 2006; 70: 1901-10

(14) Mikus PM, Dell'Amore A, Pastore S, Galie N: Pulmonary endarterectomy: is there an alternative to profound hypothermia with cardiocirculatory arrest? Eur.J.Cardiothorac.Surg. 2006; 30: 563-5

09/2006

(1) Clark SC. Lung injury after cardiopulmonary bypass. Perfusion 2006; 21(4):225-228.

(2) Cooper JR, Jr., Abrams J, Frazier OH, Radovancevic R, Radovancevic B, Bracey AW et al. Fatal pulmonary microthrombi during surgical therapy for end-stage heart failure: possible association with antifibrinolytic therapy. J Thorac Cardiovasc Surg 2006; 131(5):963-968.

(3) Dong X, Liu Y, Du M, Wang Q, Yu CT, Fan X. P38 mitogen-activated protein kinase inhibition attenuates pulmonary inflammatory response in a rat cardiopulmonary bypass model. Eur J Cardiothorac Surg 2006; 30(1):77-84.

(4) Egan TM, Haithcock JA, Nicotra WA, Koukoulis G, Inokawa H, Sevala M et al. Ex vivo evaluation of human lungs for transplant suitability. Ann Thorac Surg 2006; 81(4):1205-1213.

(5) Jiang L, Wang Q, Liu Y, Du M, Shen X, Guo X et al. Total liquid ventilation reduces lung injury in piglets after cardiopulmonary bypass. Ann Thorac Surg 2006; 82(1):124-130.

(6) Macchiarini P, Kamiya H, Hagl C, Winterhalter M, Barbera J, Karck M et al. Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: is deep hypothermia required? Eur J Cardiothorac Surg 2006; 30(2):237-241.

(7) Prekker ME, Nath DS, Walker AR, Johnson AC, Hertz MI, Herrington CS et al. Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation. J Heart Lung Transplant 2006; 25(4):371-378.

(8) Troncy E, Hubert B, Pang D, Taha R, Gauvin D, Beauchamp G et al. Pre-emptive and continuous inhaled NO counteracts the cardiopulmonary consequences of extracorporeal circulation in a pig model. Nitric Oxide 2006; 14(3):261-271.

(9) Xiao dW, Yang M, Yang J, Hon KL, Fok FT. Lung damage may induce thrombocytopenia. Platelets 2006; 17(5):347-349.

12/2005

(1) Bittner HB, Richter M, Kuntze T, Rahmel A, Dahlberg P, Hertz M et al. Aprotinin decreases reperfusion injury and allograft dysfunction in clinical lung transplantation. Eur J Cardiothorac Surg 2005; .

(2) Guillen RV, Briones FR, Marin PM, Jover AS, Represa JM, Colom AP. Lung Graft Dysfunction in the Early Postoperative Period After Lung and Heart Lung Transplantation. Transplant Proc 2005; 37(9):3994-3995.

(3) Barrow S, Cherry C, Hickey C, Kelly KS. Pulmonary thromboendarterectomy for thromboembolic pulmonary hypertension. AORN J 2005; 82(4):604-624.

(4) Mahmoud AB, Burhani MS, Hannef AA, Jamjoom AA, Al Githmi IS, Baslaim GM. Effect of modified ultrafiltration on pulmonary function after cardiopulmonary bypass. Chest 2005; 128(5):3447-3453.

(5) Hutschala D, Skhirtladze K, Zuckermann A, Wisser W, Jaksch P, Mayer-Helm BX et al. In vivo measurement of levofloxacin penetration into lung tissue after cardiac surgery. Antimicrob Agents Chemother 2005; 49(12):5107-5111.

(6) Kovesi T, Szabo A, Royston D, Marczin N. Correlation between pulmonary gas exchange and basal and nitroglycerin (GTN)-induced exhaled nitric oxide (eNO) in patients undergoing cardiac surgery. Vascul Pharmacol 2005; 43(6):434-440.

(7) Reis MD, Gommers D, Struijs A, Dekker R, Mekel J, Feelders R et al. Ventilation according to the open lung concept attenuates pulmonary inflammatory response in cardiac surgery. Eur J Cardiothorac Surg 2005; 28(6):889-895.

(8) Langer F, Bauer M, Tscholl D, Schramm R, Kunihara T, Lausberg H et al. Circulating big endothelin-1: an active role in pulmonary thromboendarterectomy? J Thorac Cardiovasc Surg 2005; 130(5):1342-1347.

(9) Zegdi R, Fabiani JN. Exhaled nitric oxide after cardiopulmonary bypass. Ann Thorac Surg 2005; 80(5):1977-1978.

(10) El Kebir D, Hubert B, Taha R, Troncy E, Wang T, Gauvin D et al. Effects of inhaled nitric oxide on inflammation and apoptosis after cardiopulmonary bypass. Chest 2005; 128(4):2910-2917.

(11) Hedenstierna G. When shall the lung be opened up: during or after cardiac surgery? Crit Care Med 2005; 33(10):2425-2426.

(12) Sheil ML, Luxford C, Davies MJ, Peat JK, Nunn G, Celermajer DS. Protein oxidation injury occurs during pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 2005; 130(4):1054-1061.

(13) Verheij J, van Lingen A, Raijmakers PG, Spijkstra JJ, Girbes AR, Jansen EK et al. Pulmonary abnormalities after cardiac surgery are better explained by atelectasis than by increased permeability oedema. Acta Anaesthesiol Scand 2005; 49(9):1302-1310.

(14) Wrigge H, Uhlig U, Baumgarten G, Menzenbach J, Zinserling J, Ernst M et al. Mechanical ventilation strategies and inflammatory responses to cardiac surgery: a prospective randomized clinical trial. Intensive Care Med 2005; 31(10):1379-1387.